Buchumschlag

Enhancing Prostate Cancer Diagnosis: The Combined Value of PHI and mpMRI

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Y. M. Yáñez‐Castillo, M. T. Melgarejo‐Segura, M. A. Arrabal‐Polo, A. Jiménez‐Pacheco, J. V. García‐Larios, T. De Haro Muñoz, P. Lardelli‐Claret, J. L. Martín‐Rodríguez, M. Arrabal‐Martín
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	The Prostate
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

The detection rate for prostate cancer in systematic and targeted prostate biopsy in biopsy‐naive patients, according to the localization of the lesion at the mpMRI: A single‐center retrospective observational study
von: Matteo Massanova, et al.
Veröffentlicht: (2024)

Prostate Volume and PSA‐Density Estimation by Transabdominal Ultrasound: Prospective Evidence of Comparative Accuracy to MRI and Transrectal Ultrasound in Prostate Cancer Early Diagnostics
von: Liza M. Kurucz, et al.
Veröffentlicht: (2025)

[ 18 F] PSMA PET‐CT and [ 18 F] Choline PET‐CT in the Diagnosis of High‐Risk Localized Prostate Cancer: Comparation of Both Tests
von: M. A. Tárraga‐Honrubia, et al.
Veröffentlicht: (2026)

Combining Prostate‐Specific Antigen Density With PI‐RADS to Improve the Detection of Clinically Significant Prostate Cancer at MRI/TRUS Fusion‐Targeted Re‐Biopsy
von: Yuto Ono, et al.
Veröffentlicht: (2025)

Racial Disparities in the Use of MRI and PET Scan Among Medicare Beneficiaries With Prostate Cancer
von: Hanna Zurl, et al.
Veröffentlicht: (2025)

Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features
von: Tatsuya Shimomura, et al.
Veröffentlicht: (2026)

Castration Resistance Accelerates Prostate Cancer Kinetics
von: Sheila Jonnatan, et al.
Veröffentlicht: (2026)

Safety and Efficacy of Bipolar Transurethral Vaporization of the Prostate and Bipolar Transurethral Resection of the Prostate in the Management of Large Volume Benign Prostatic Hyperplasia: A Prospective Randomized Study
von: Amr M. Lotfy, et al.
Veröffentlicht: (2026)

The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate
von: Yifu Shi, et al.
Veröffentlicht: (2025)

Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer
von: Marta Victoria Lorenzo‐Sánchez, et al.
Veröffentlicht: (2025)

Muscadine Grape Skin Extract in Biochemically Recurrent Prostate Cancer: A Randomized, Placebo‐Controlled, Biomarker‐Enriched Trial in Patients With the SOD2 Ala/Ala Variant
von: A. Mandl, et al.
Veröffentlicht: (2025)

Pathology of a Canine Model of Localized Prostate Carcinoma
von: Nathan K. Hoggard, et al.
Veröffentlicht: (2025)

Prostate Specific Antigen Density and Clinically‐Significant Prostate Cancer: The Influence of Prostatic Volume
von: Elizabeth Robinson, et al.
Veröffentlicht: (2025)

Late Bowel Symptoms in Long‐Term Survivors of Prostate Cancer Following Radiotherapy
von: Isabella Gruber, et al.
Veröffentlicht: (2025)

Cumulative cancer locations on prostate biopsy and active surveillance outcomes in the MRI era
von: Sean A. Fletcher, et al.
Veröffentlicht: (2024)

Comparative Evaluation of Detection Rates for Clinically Significant Prostate Cancer Using MRI‐Targeted Biopsy Alone Versus in Combination With Systematic Biopsies: Development of a Risk‐Stratification Scoring System
von: Toshifumi Takahashi, et al.
Veröffentlicht: (2024)

ERG and PTEN Role on Active Surveillance for Low‐Risk Prostate Cancer in the Multiparametric MRI Era
von: Marco Aurelio Watanabe Yorioka, et al.
Veröffentlicht: (2024)

The Diagnostic Value of Plasma Small Extracellular Vesicle‐Derived CAIX Protein in Prostate Cancer and Clinically Significant Prostate Cancer: A Study on Predictive Models
von: Haotian Chen, et al.
Veröffentlicht: (2025)

Mapping Molecular Diversity in Prostate Cancer With a Combined Multiplex IHC and RNA‐ISH Assay
von: Shannon Carskadon, et al.
Veröffentlicht: (2025)

The Role of Secondary Lesion Biopsy in Detecting Clinically Significant Prostate Cancer
von: Trevor C. Hunt, et al.
Veröffentlicht: (2025)

Reply – Letter to the Editor: Bimodal Imaging at MRI Fusion Prostate Biopsy Will Gain Further Importance in the Future
von: Fabian Falkenbach, et al.
Veröffentlicht: (2025)

CHARGE: The “Big Questions” in Prostate Cancer for 2024
von: Andrea K. Miyahira, et al.
Veröffentlicht: (2024)

Prostate Extracellular Vesicles and Prognostic Biomarkers of Clinically Significant Prostate Cancer: A Prospective Single‐Institution Pilot Study
von: Cameron J. Britton, et al.
Veröffentlicht: (2025)

Incidental Brain Metastases From Prostate Cancer Diagnosed With PSMA PET/CT and MRI: A Case Series and Literature Review
von: Mark Willy L. Mondia, et al.
Veröffentlicht: (2025)

Nectin‐4 Expression in Prostatic Adenocarcinoma: An Immunohistochemical Study
von: Ezra G. Baraban, et al.
Veröffentlicht: (2025)

Altered Ten Eleven Translocation Methylcytosine Dioxygenase Expression and DNA Hydroxymethylation in a Mouse Model of Prostate Cancer
von: Matthew Aguilera, et al.
Veröffentlicht: (2025)

Metformin and Flutamide Combination Therapy’s Efficacy and Safety in Prostate Cancer Cell Lines
von: AhmadReza Rezaeian, et al.
Veröffentlicht: (2026)

Reliability of Negative Prostate MRI for Biopsy Decision‐Making in the Male Han Chinese Population
von: Fangming Wang, et al.
Veröffentlicht: (2026)

Spatial Distribution of Prostate Cancer Missed by MRI‐Targeted Biopsy, Effect of a Perilesional Template, and Restaging in a Radical Prostatectomy Cohort
von: Ruth Himmelsbach, et al.
Veröffentlicht: (2026)

Association of Escherichia coli Infection and fimh Virulence With Benign Prostatic Hyperplasia in Ghanaian Patients
von: Yvonne Anang, et al.
Veröffentlicht: (2025)

Surveillance Versus Treatment for Favorable Intermediate‐Risk Prostate Cancer and Mortality‐Risk
von: Mutlay Sayan, et al.
Veröffentlicht: (2026)

Genetic Testing Among Black and White Patients With Advanced Prostate Cancer: A Retrospective Analysis of Testing Utilization and Referral Patterns
von: Kyle C. McElyea, et al.
Veröffentlicht: (2025)

Socioeconomic and Demographic Factors in Genetic Testing Utilization Among Advanced Prostate Cancer Patients
von: Alexandra T. Skowron, et al.
Veröffentlicht: (2026)

The Effects of the Blood‐Based S2,3PSA% Test on Prostate Cancer Screening: A Novel Approach to Reduce the Need for MRI and Unnecessary Biopsies
von: Hikari Miura, et al.
Veröffentlicht: (2025)

Prostate‐Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone‐Sensitive Prostate Cancer Treated With Apalutamide
von: Christian Andrés Martínez Osorio, et al.
Veröffentlicht: (2025)

Second Therapeutic Freeze After Salvage Cryoablation for Localized Radiorecurrent Prostate Cancer
von: Sudharshanan Balaji, et al.
Veröffentlicht: (2026)

Survival Outcomes for Rural Patients With Advanced Prostate Cancer: A SEER Investigation
von: Liang G. Qu, et al.
Veröffentlicht: (2025)

Enhancing Diagnostic Accuracy in Prostate Oncology: A Multidimensional Perspective on Prostate Specific Antigen Density
von: Shengyi Chen, et al.
Veröffentlicht: (2025)

pSTAT3 Expression is Increased in Advanced Prostate Cancer in Post‐Initiation of Androgen Deprivation Therapy
von: Piotr Bialas, et al.
Veröffentlicht: (2024)

Hormone Therapy Usage Is Associated With Adverse Cardiovascular Events in Prostate Cancer Patients of the All of Us Research Program Cohort
von: Yuanchu J. Yang, et al.
Veröffentlicht: (2025)